7¢. Your missing the signals guys/gals looking too much at Viraleze, other products, CEO, BOD etc, read the signals my friend's there is a major DEP Move in. Hi all, I think it would be in all of our best interests if each of us sent an email to SPL investor relations and voiced our concerns. 37pm 10/11/2023 ? HotCopper has news, discussion, prices and market data on WHISPIR LIMITED. Our magic little formula may just be the answer. 0. Looking at the short term, SPL's SP is currently perched above a technical support line at 50 cents. Dr. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). When it goes to 62 cents, and it will as it's 1 cent away, it will be a 282-week low, or 5 years 8 months since it's been at that level, that's a lot of holders if not all on them in the red. Charts. . Starpharma is listed on the Australian stock exchange (ASX:SPL). They are the future as also mentioned regularly by Eric Topol. I will be unable to listen to the AGM but look forward to listening to the audio and reading Hotcopper comments and feed back after my afternoon shift. SPL - still awaiting human trials!Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. It looks like SPL will need a BLOCKBUSTER ANNOUNCEMENT with $$$$$ attached plus a SATURN ROCKET up its clacker to take off. . Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. The digital display offers a 0. Once they think they can get AZD0466 to market they will pounce if our share price is less tan $2. With SPL we have entered a relatively short term period where things are going to develop into something serious. 47pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on NOVONIX LIMITED. Some paralllels with SPL, although every product and data is different, but a least MSB are pretty clear with CRL - not pretty fro shareholders and going to take a lot of funding and dillution to achieve trial that could have been completesd in that same timeframe and IMO a lower risk. 2:00 am Eastern Standard Time Australia. Last updated 14. FDA, TGA, MHRA to pick fights and get knocked out and 2 blood noses. ASX - Day TradingMelbourne, Australia; 8 December 2022: Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) today announces that it has commenced recruitment in the UK for a post- market clinical study of its broad-spectrum antiviral barrier nasal spray, VIRALEZETM, in patients with COVID-19, following receipt of the necessary regulatory and ethics. SUBMISSION STEPS. Discussion. To be fair the ASX has made tries on 3 recent contracts to squeeze information from SPL when didn’t want to disclose how immaterial the contracts is. 1. The bait SPL have put out about models and publishing in 3 weeks should be stopped by ASX / ASIC and teh timing is odd IMO. 57% 13. A new DFS upgrade has expanded operation capacity on-site the project from 15 gigawatt hour’s worth of battery production to 120GWh. Created with Sketch. 0¢. 0¢. Follow your favourite stocks, view charts, track gainers and losers and discuss topics including politics, commodities, cryptocurrency and managed funds. Created with Sketch. Yes I think SPL does have a future but TIME is of the essence. Latest Posts. 0¢. The SP must break out of the. Attached link highlights some of the complexities involved more broadly. SPL Price at posting: 71. Created with Sketch. Do they actually work day in day out? Do research everyday? If so why after 20 years we are still at phase 1/2. In March 2020 the SPL share price dropped to a low of 0. Forums. . Everyone holding SPL shares should now realise that unless they can have a deal signed on at least one of the Dep candidates within 3 to 6 months with a substantial. . Not going to go over all the posts that are detailing what the spl7013 antiviral nasal spray may mean to the world others have done a great job. Interesting write-up. Follow your favourite stocks, view charts, track. IMO they haven't . Canadian Dollar. Created with Sketch. FORTESCUE METALS GROUP LTD. 0000. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Join the HotCopper ASX share market forum today for free. Market . podcasts, and hotcopper) Reading announcements from Starpharma and having to decipher what is actually being said And finally, lacking the ability to sell our products currently. SPL. ASX - By Stock. 5 cents. . 11%. Forums. And somebody must be buying all the shares that are being sold. We love cruising, but this multi billion dollar industry has effectively been shut down. One of those is worse that SPL. . Join the HotCopper ASX share market forum today for free. Starpharma (SPL) Shares in the nano-biotechnology group bucked the falls in the wider market on Monday after it announced a deal with a division of US pharmaceutical giant Ely Lilly to extend the application of its technologies in the animal health area. They need IMO to define good and any other qualifying words !!. The rules obviously do not apply in Starpharma Land with CEO Jackie Fairley. 5 years Starpharma has not publicly released any information to the ASX about progress of the partnership. . . 00 and $5. OR no reponse at all. I no longer regard SPL as an investment-grade stock. Last updated 15. ASX - By Stock. Share Financial Analysis: "Dr Jackie Fairley, CEO, Starpharma, commented:These very positive results for DEP® cabazitaxel in three common and hard-to-treat cancers demonstrate its therapeutic and commercial value" The phase 2 results look great and certainly demonstrate therapeutic value. Fortescue Metals Group Ltd (Fortescue) is an Australia-based company engaged in iron ore. I have just sent. ASX - Short Term Trading. 138. Just to make sure we are all on the same page as far as AZD0466 is concerned The data available from the AACR SCLC Abstract (April 19th 2023) was from January 24th 2023 (it is out of date by more than 3 months)Fresh off the press 10th May 2023 The NHL trial is accelerating at a rapid rate Fyi 23 sites recruiting out 29 locations Since last update 8 additional. . The matter has been adjourned to. 40. Created with Sketch. Share Interesting and positive early pre-clinical results. Advertise on HotCopper. . I know that Company's have to concentrate on the task at hand but an awareness of the World Economy is important. 6% (1. 8¢. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . ,), Okamoto, LifeStyles, Aspen and Mundipharma. . 00%. I think that the more time that passes without profits, the less likely that there will ever be profits. The upper and lower pennant lines will intersect in three months. S. The latest Hotcopper Holdings [HOT] news, articles, data and analysis from The Australian Financial Review About this app. Application for quotation of securities - SPL. 37 Sentiment: Buy Disclosure: Held. Dec 14 (Reuters) - Starpharma Holdings Ltd (SPL) : VIRALEZE NASAL SPRAY REGISTERED IN INDONESIA PROGRESSING DISCUSSIONS WITH POTENTIAL DISTRIBUTION. 1. HotCopper is Australia's largest free and independent stock market trading forum for ASX investors to discuss share prices, the stock market and more. 0. Target our investor community with our suite of Hotcopper Advertising opportunities. Along with SPL's seemingly better ADC compared to AZ's Enhertu, perhaps Pascal Soriot is wondering if he jumped into bed with the the wrong partner in Daiichi-Sankyo. Canadian Dollar. . . ASX - By Stock. Views. Its a boring market today and I had time to revisit SPL, where I am a long, long time weary holder. Application for quotation of securities - SPL. ASX - Day TradingI will just put it out there that I have been peeved off about our CEO Jackie Fairley and the performance of SPL for a while now. 0. Charts. Viraleze being 1% less efficacious against the more potent dangerous new strains is an awesome result and should be celebrated. Hey, "smart", I concur with your message. This is a charting thread for those interested in the movements of the SPL SP. . Firstly, I’m a big fan of SPL and proud of all of their achievements to date (even picked up a few more shares the other day). Feb 28 (Reuters) - Starpharma Holdings Ltd (SPL) : HY REVENUE FROM CONTINUING OPERATIONS DOWN 16% TO A$1. Phillip Altman is a highly-respected and well-known Australian authority on clinical trials and drug regulatory affairs with more than 40 years of experience in designing, managing and reporting of clinical trials and in working with the Australian Therapeutic Goods Administration (TGA) in gaining new drug approvals. Join the HotCopper ASX share. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . All IMO this highlights the problems with agreements where there is seemingly no min order quantity and obligation to advertise and promote the product. ASX - By Stock. it's a mess with multiple Substantial Holders dumping like this all while HQ remain. Yes I am sure @sarge17 some will come on here today that have been predicting a $2 share price for more than 6 months because it has finally hit that target today saying “I toldNotification of cessation of securities - SPL. ASX - By Stock. We, as investors in this company deserve to knowmore. . 59pm 23/11/2023 ? HotCopper has news, discussion, prices and market data on MESOBLAST LIMITED. . I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. When a board member uses rheir own hard earned cash and buys $350,000 worth of shares. 0¢ Sentiment: None Disclosure: Not HeldHi FolksIts a boring market today and I had time to revisit SPL, where I am a long, long time weary holder. Despite the length of time that SPL has been in existence, it is obvious that some players think that SPL is currently overvalued, hence the relentless selling. Latest Posts. Quarterly Activities Report & Appendix 4CLooking further into the AGM notice, Resolution 3 is a massive slap in the face to share holders!!!Basically the company is proposing to dish out a bonus. ASX - Day TradingHi guys, I have held SPL shares for over 9 years and I will continue to hold. )” ~@antibotter Jan 2019 (Hotcopper post #37005569) After ASX announcement ‘Positive DEP phase 2 interim results in prostate cancer’:Peak of the UK Flu season looks to have passed . 36. Both were very well paid and, if the "forward looking statements" are to be believed would have had the box seat in a company with a great future. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Forums. HotCopper has news,. Share I sometimes wonder if they actually work at Starpharma. In SPL's case there is clearly another. Click for. Created with Sketch. This extract caught my eye"The AstraZeneca programs involves $US124 million of milestones, about half of which are “relatively near”. Latest Posts. . Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. 375) mark and followed up with a roughly 23. 83453. NEVER - there should be an official corruption enquiry considering the Gov Funding and R&D reimbursements recieved by SPL and what actually was achieved and why they haven't been succesful - there's US companies flogging Povidine Iodine nasal spray and throat sprays left right and centre. And it’s at least good to see that the ASX has demanded supplementary information from Starpharma on numerous occasions recently. This is what faces SPL's DEP product business, and so far they seem incapable of fighting through the maze to get recognised and accepted. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Created with Sketch. Join the HotCopper ASX share market forum today for free. SPL have hit road blocks with many of their products. The latest Hotcopper Holdings [HOT] news, articles, data and analysis from The Australian Financial ReviewAbout this app. Created with Sketch. Last updated 15. The recent announcement about Viraleze nasal. HotCopper has news, discussion, prices and market data on SPLITIT PAYMENTS LTD. 0¢. 48. 75. 3¢. I constantly question why I continue to subject myself to the ongoing. Or primary care stop like a medical centre or clinic- stating the obvious- hope SPL have better marketers than I) Also would like to see what the USA have done to allow retail investor to get involved in per IPO rather than just institutions investors getting the huge discount to Share Price. It is easy to be a negative poster on here when there has not been anything positive to come out of the company for a looooong time. Just as I thought - both @antibotter and JF & Co. . So much coming up with Viraleze and DEP Starpharma team will be working very hard at the moment with so many balls in the air. 22%) 3,361,416 was the lowest point of total short sales for some years as of 15/06/23 (0. ASX - Day Trading. ASX - Day TradingLast day Spl remains in ASX300 Institutions and/or shorters buying TIME LINE At auction today there were 20 million shares wanted to buy and 11 millions shares wanted to sell Notice after close of auction there were still 10 million shares wanted to buy and 450k to sellThe deal, which has an initial duration of 12 months, has the same terms as the previous agreement. Created with Sketch. Friday 26/06/2020 looks like the slide deck is very similar if not identical to last Friday's audio presentation I will be recording audio just in case this audio presentation is different SPL management team get bad marks for delays all the time but I don’t read anyone citing possible reasons. It would be nice to have SPL make an announcement to the market to clear up the uncertainty around the many market sensitive announcements made that seem to have just faded into the background with no update as to whether they are progressing or if they have ceased. 2663916. HotCopper is Australia's largest free and independent stock market trading forum for ASX share prices & stock market discussions. No change of interest notification received. Forums. 3¢. More. RDN Raiden Resources secures complete control of lithium at Arrow Project, buys out Arrow Minerals Ltd. Good luck to all. AZ will be watching Phase 2 results and assessing the market against the potential SPL bill. 57pm 13/11/2023 ? HotCopper has news, discussion, prices and market data on SUNRISE ENERGY METALS LIMITED. Share Given the current status of Starpharma, I am surprised any of these made it through from 2020 but it appears 121,082 did. 10/10/23. (OTCQX: SPHRY | ASX: SPL) Thursday, June 25, 2020 12:00 p. Join the HotCopper ASX share market forum today for free. are either confused or talking nonsense. Just to refresh people's memory I thought this summed by the exact situation with the TGA and Starpharm STARPHARMA’S COVID-KILLER NEEDS ACTION NOT. Hey, "smart", I concur with your message. 1. The purpose of many of us working in pharmaceutical research and development whether within the industry or academia is to deliver medicines to improve the lives of patients around the world. Market . 199920. ASX - Day TradingCreated with Sketch. my apologies that I could not stay after the. 14. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Hey, "smart", I concur with your message. Hey, "smart", I concur with your message. Some days I wondered if I'd see 91c again, but when the Vivagel phase 3 announcement came out I loaded up big time. ASX - Day Trading. Last updated 10. Eight (8) contributors to the HC SPL thread made price predictions (thank. HotCopper is an Australian stock market online chat forum that allows its users to discuss financial topics. * The Viraleze trial will be completed. 5¢. So far no one wants to add anything except to get. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Market . Some links within this article worth a scan too. Forums. Last edited by sarge17 : 19/09/20 SPL Price at posting: $1. 00. opportunities galore IMO but we are likely to miss the boat again based on past performance of JF & Co. $0. Advertise on HotCopper. Created with Sketch. Forums. DISCOVER THE BATTERY METALS. This product was expected to produce rivers of. 8985. 5¢ Sentiment: Sell Disclosure: Not HeldThe one positive sign is that AstraZeneca are continuing to expand site recruitment for both AZD0466 trials. Comments. See All Discussions. 50 At this stage in the game, I would not accept anything under $5 (fact)Btw if Starpharma do receive an upfront milestone of $300 million for Dep Docetaxel, Dep Cabazitaxel and Dep Irinotecan license, I believe a special dividend will be paid out to all. I think SPL are very worried on what a potential class action could implicate. Nope. 5¢. This extract caught my eye"The AstraZeneca programs involves $US124 million of milestones, about half of which are “relatively near”. 5¢. With EOFY selling about to hit us like a freight train, where does everyone think the bottom will be for SPL' shareprice?Unless one of the many promises. Market . Name/company Polymer Drug, class/loading method Delivery system type/size Clinical stage/indication; CPC634. As Waldemar Januszczak said when looking at the portrait of Mr & Mrs Andrews by Gainsborough "THERE IS SOMETHING GOING ON here". Resolutons 2,3 &4. Please type the title in sentence case (that is lowercase with only the first letter or the first word in capitals) and without any punctuation. 74. ASX - Day TradingDoes Spl deserve to be seven times less in mkt cap to another biotech that has one phase 2 product spl potentially 3 and commercialisation deal with astra zeneca and collaboration deals with Merck and Genentech. . 5. m. ASX - Short Term Trading. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Hope that SPL starts to deliver on its promises. 26. Forums. This of course is on the back of long-serving lap dog and CFO/Secretary Nigel Baade resigning around the same time that the ASX asked Starpharma questions regarding continuous disclosure obligations and also whether a SPL announcement was tantamount to ramping. Created with Sketch. 0000. 8985. A trader who used stock forum HotCopper to pump and dump about 20 penny stocks using 13 trading accounts has been given a jail term of 2½ years, but is being released immediately on a five-year. great news but unlikely. Market Cap $55. 0¢ STARPHARMA HOLDINGS LIMITED - Corporate Spotlight . Cristal therapeutics. ASX - By Stock. Deliver ZERO dividends, a NEGATIVE capital return and depressed share price to shareholders over a 17 year period. Forums. 615, today the share price rose by 0. Last updated 14. . Market . . 2327/7/2021 CSL $292. ASX - By Stock. 0. BCSPL – VI Wave. ASX - By Stock. Forums. I have no problem with the way SPL accessed the market initially but percieved issues over time and this may be one. Click for more information. 5,006,219 was the total short sales as of 21/07/23 (1. ASIC said Govinda faces a maximum penalty for each charge of 10 years’ prison, or a fine of up to $765,000, or both, after he entered the guilty pleas on Monday. Some years ago SPL failed an FDA trial for the same product when Jackie was CEO. Views. Latest Posts. Starpharma is a world leader in the development of new medical products based on its proprietary dendrimer technology and has partnerships with leading global companies, including AstraZeneca, MSD (Merck & Co. AX8. HotCopper is Australia's largest free and independent stock market trading forum for. Created with Sketch. The real story is SPL hasn't been 63 cents since 24/3/2020 that's not a 52-week low, that's a 114-week low! 2 years 3 months since its seen that price. If only we had the viraleze. It’s unlikely to happen, but personally I hope Rob Thomas and Jackie Fairley fall on their sword prior to the AGM. 0 Great. Norman Swan interviewed on ABC RN Breakfast talks about Covid Nasal vaccines and blockers. ASX - By Stock. “Who in at SPL made these commitments on timelines?” ~ @Joelsmith2452 CEO Jackie Fairley first told shareholders that the current Phase 2 DEP-Docetaxel trial would be complete by the end of CY2018. 0¢. Created with Sketch. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Remember that according to AZ’s own data, no patient had yet met the formal criteria of a response. . 8¢. I wonder if LLoyds are taking the pain on 50% off or if SPL rebating just to get volume and name in market ? LLoyds depending on agreemnet would usually just return stock IMO. 63. ASX - Day TradingShare Can you point out what you believe are their failings with respect to regulatory filings for a "medical device"? Also do you consider that government and regulatory sentiment may have had an impact on consumer demand and any advertising plan - its clear that Governments are still fixated on Vaccination to the disregard of any. Created with Sketch. Latest Posts. any other information the entity wishes to notify to ASX about the cessation?The Performance Rights issued under an employee incentive scheme lapsed during the course of the quarter ended 30June 2023 include 519,053 Rights held by KMP, Nigel Baade, and 310,760 Rights held by non-KMPs. Join the HotCopper ASX share market forum today for free. ASX - Day Trading Last day Spl remains in ASX300 Institutions and/or shorters buying TIME LINE At auction today there were 20 million shares wanted to buy and 11 millions shares wanted to sell Notice after close of auction there were still 10 million shares wanted to buy and 450k to sell Merck has tightened its ties to Starpharma as it continues to build out its antibody-drug conjugate (ADC) capabilities, signing a second agreement that will enable it to evaluate candidates based. 52pm 13/10/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. LEADING THE BATTERY METALS REVOLUTION. The lab that is. Forums. Created with Sketch. However, just a word of caution before the usual pumping starts by the usual suspects. 37. yet if one considers that the amount of millions of shares via option they. ASX - Day Trading. 3. Last updated 15. Notification of cessation of securities - SPL. Although with SPL's track record an exceptionally good news announcement seems unlikely, it is within the realms of possibility - and this seems to be what makes SPL worth a gamble. distraction achieved. ASX - Short Term Trading. J K Fairley $1,272,084N J Baade. Created with Sketch. 0%. I am not up to date with all brexit stuff let alone othe rcountries like Vietnam , HK and very cautiious about consultants websites and simply govt websites area nightmare to understand and navigate unless it is your speciality. No China virus, no Flu, no colds. Add SPL (ASX) to my watchlist (20min delay). Join the HotCopper ASX share market forum today for free. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Created with Sketch. Market . See All Discussions. Labcorp Contacts: Media: Michele Mazur — 336-436-8263 Media@Labcorp. . ASX - By Stock Forum | Join the HotCopper forum today for free. Hey, "smart", I concur with your message. 52pm 13/10/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. ASX - Short. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products .